Diabetes is a widespread disease with serious complications affecting multiple organs. Renal complications are among the most significant ones. In fact, about 40% of patients requiring dialysis are diabetic. Until a few years ago, there were no drugs capable of treating the renal complications of diabetes, so dialysis was the norm. Yet today there are a new series of therapies that can delay and, in some cases, eliminate the need for dialysis. This and much more will be discussed at the International Diabetology Conference scheduled in Naples from February 25 to 28, 2026. The event is organized by the Biogem Scientific Director, Professor Giovambattista Capasso, together with Dr. Silvio Settembrini.

In particular, during the conference, Professor Capasso has organized the second international conference on diabetic kidney disease, entitled "New Frontiers in Diabetic Kidney Disease: From Mechanisms to Patient Care." On Friday, February 27, from 9:00 a.m. to 6:15 p.m., some of the world's leading experts in kidney disease, diabetes, and their correlations will deliver their talks. The conference is being held under the patronage of Biogem and the ERA (European Renal Association), which will be represented by its current president, Professor Roser Torra, who will deliver the closing keynote address.

In addition to Professor Capasso, many members of the Nephrology and Dialysis Unit at the University of Naples L. Vanvitelli, which has enjoyed a strong clinical and scientific collaboration with Biogem for several years, will participate at the conference. Among others, Professor Francesco Trepiccione, head of Biogem's Nephrology Section, and Professors Alessandra Perna, Miriam Zacchia, Mariadelina Simeoni, and Giovanna Capolongo. The presence of Professor Vincenzo Carafa, co-head of Biogem's epigenetics laboratory, confirms that Biogem is at the forefront of international research about the effects of diabetes on kidney function.

For more information: https://www.napolidiabetologia.it/